Hunger Control Expert | Cagrilintide + Semaglutide/Tirzepatide Combo Therapy
Core Mechanism: Dual GLP-1/Amylin receptor activation reduces daily hunger signals by 47% (Phase II clinical data).
Technical Edge: Lyophilized formulation (-20℃ stable) with IV/SC administration protocols.
Research Application: Preoperative weight optimization for bariatric surgery candidates (BMI>30).
Compliance: cGMP manufacturing per 21 CFR 210/211.
Global Peptide Solutions Provider
Specializing in GMP-certified peptide R&D, production & distribution for biomedical research and healthcare sectors.
Core Competencies
• End-to-End Expertise: Molecular design to global cold chain logistics
• Scaled Capacity: 100,000+ units/month in 10,000㎡ ISO 13485 facility
• Quality Control: 3-stage testing (HPLC/MS dual verification, >99% purity)
• Global Reach: 50+ countries via US/EU/SG hubs with blockchain traceability
Flagship Products
▸ Weight Management: Semaglutide, Tirzepatide, Cagrilintide
▸ Tissue Repair: BPC-157 (multifunctional recovery)
▸ Next-Gen Solutions: Antimicrobial & anti-aging peptides
Operational Excellence
✓ Stability: 36-month validated shelf life at 25°C/60% RH
✓ Logistics: GPS-tracked cold chain with DDP clearance (72hr dispatch)
✓ Compliance: USP/EP standards & automated lyophilization
Client Support
• Shipping: 5-9 business days via DHL/FedEx/Dedicated Line
• Payment: Bank Transfer/Crypto/Alibaba Trade Assurance
• Guarantee: Damaged/lost order replacement & real-time tracking
Telegram: @HelenTT
Whatsapp:+12139973355
Контакти
Форма за контакт
Hunger Control Expert | Cagrilintide + Semaglutide/Tirzepatide Combo Therapy 0 reviews
Write Your ReviewThere are no reviews yet.